Novel targets for the treatment of retina diseases

Details for Australian Patent Application No. 2004269920 (hide)

Owner Association Francaise Retinitis Pigmentosa (AFRP) Universite Rene Descartes Paris V

Inventors Marchant, Dominique; Menasche, Maurice; Van Den Berghe, Loic; Gadin, Stephanie; Sainton, Karine; Abitbol, Marc

Agent Blake Dawson Waldron

Pub. Number AU-A-2004269920

PCT Pub. Number WO2005/023311

Priority 60/502,123 11.09.03 US

Filing date 10 September 2004

Wipo publication date 17 March 2005

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

30 March 2006 PCT application entered the National Phase

  PCT publication WO2005/023311 Priority application(s): WO2005/023311

19 June 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004269923-Use of PDE4 inhibitors for the treatment of diabetes mellitus

2004269910-Compositions comprising benzo (G) quinoline derivatives and prostaglandin derivatives